UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD-DTN): Best practice guide for hybrid closed-loop therapy

被引：19

作者：

Griffin, Tomas P. ^{[1
,2
,3
,4
]}

Gallen, Geraldine ^{[5
]}

Hartnell, Sara ^{[6
]}

Crabtree, Thomas ^{[7
,8
]}

Holloway, Melissa

Gibb, Fraser W. W. ^{[9
]}

Lumb, Alistair ^{[10
,11
]}

Wilmot, Emma G. G. ^{[7
,8
]}

Choudhary, Pratik ^{[1
,2
]}

Hussain, Sufyan ^{[5
,12
]}

机构：

[1] Univ Hosp Leicester, Leicester Diabet Ctr, Leicester, England

[2] Univ Leicester, Coll Hlth Sci, Diabet Res Ctr, Leicester, England

[3] Univ Limerick, Sch Med, Limerick, Ireland

[4] Univ Hosp Limerick, Ctr Diabet & Endocrinol, Limerick, Ireland

[5] Kings Coll London, Sch Cardiovasc Metab Med & Sci, Dept Diabet, London SE1 9RT, England

[6] Cambridge Univ Hosp NHS Fdn Trust, Dept Diabet & Endocrinol, Cambridge, England

[7] Univ Hosp Derby & Burton NHS Fdn Trust, Derby, England

[8] Univ Nottingham, Translat Med Sci, Nottingham, England

[9] Royal Infirm Edinburgh NHS Trust, Edinburgh Ctr Endocrinol & Diabet, Edinburgh, Scotland

[10] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England

[11] Oxford NIHR Biomed Res Ctr, Oxford, England

[12] Guys & St Thomas NHS Fdn Trust, Dept Diabet & Endocrinol, London, England

来源：

DIABETIC MEDICINE | 2023年 / 40卷 / 07期

基金：

英国医学研究理事会;

关键词：

artificial pancreas; automated insulin delivery systems; continuous glucose monitoring; hybrid closed loop; insulin pumps; type; 1; diabetes; MANAGEMENT; OUTCOMES;

D O I：

10.1111/dme.15078

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This best practice guide is written with the aim of providing an overview of current hybrid closed-loop (HCL) systems in use within the United Kingdom's (UK) National Health Service (NHS) and to provide education and advice for their management on both an individual and clinical service level. The environment of diabetes technology, and particularly HCL systems, is rapidly evolving. The past decade has seen unprecedented advances in the development of HCL systems. These systems improve glycaemic outcomes and reduce the burden of treatment for people with type 1 diabetes (pwT1D). It is anticipated that access to these systems will increase in England as a result of updates in National Institute of Health and Care Excellence (NICE) guidance providing broader support for the use of real-time continuous glucose monitoring (CGM) for pwT1D. NICE is currently undertaking multiple-technology appraisal into HCL systems. Based on experience from centres involved in supporting advanced technologies as well as from the recent NHS England HCL pilot, this guide is intended to provide healthcare professionals with UK expert consensus on the best practice for initiation, optimisation and ongoing management of HCL therapy.

引用

页数：21

共 42 条

[31]

NICE Guideline in Development (GID-TA10845), GIDTA10845 NICE

[32] Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice [J].

Phillip, Moshe ;

Nimri, Revital ;

Bergenstal, Richard M. ;

Barnard-Kelly, Katharine ;

Danne, Thomas ;

Hovorka, Roman ;

Kovatchev, Boris P. ;

Messer, Laurel H. ;

Parkin, Christopher G. ;

Ambler-Osborn, Louise ;

Amiel, Stephanie A. ;

Bally, Lia ;

Beck, Roy W. ;

Biester, Sarah ;

Biester, Torben ;

Blanchette, Julia E. ;

Bosi, Emanuele ;

Boughton, Charlotte K. ;

Breton, Marc D. ;

Brown, Sue A. ;

Buckingham, Bruce A. ;

Cai, Albert ;

Carlson, Anders L. ;

Castle, Jessica R. ;

Choudhary, Pratik ;

Close, Kelly L. ;

Cobelli, Claudio ;

Criego, Amy B. ;

Davis, Elizabeth ;

de Beaufort, Carine ;

de Bock, Martin, I ;

DeSalvo, Daniel J. ;

DeVries, J. Hans ;

Dovc, Klemen ;

Doyle, Francis J. ;

Ekhlaspour, Laya ;

Shvalb, Naama Fisch ;

Forlenza, Gregory P. ;

Gallen, Geraldine ;

Garg, Satish K. ;

Gershenoff, Dana C. ;

Gonder-Frederick, Linda A. ;

Haidar, Ahmad ;

Hartnell, Sara ;

Heinemann, Lutz ;

Heller, Simon ;

Hirsch, Irl B. ;

Hood, Korey K. ;

Isaacs, Diana ;

Klonoff, David C. .

ENDOCRINE REVIEWS, 2023, 44 (02) :254-280

[33] Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology [J].

Pinsker, Jordan E. ;

Mueller, Lars ;

Constantin, Alexandra ;

Leas, Scott ;

Manning, Michelle ;

McElwee Malloy, Molly ;

Singh, Harsimran ;

Habif, Steph .

DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (02) :120-127

[34] Exercise management in type 1 diabetes: a consensus statement [J].

Riddell, Michael C. ;

Gallen, Ian W. ;

Smart, Carmel E. ;

Taplin, Craig E. ;

Adolfsson, Peter ;

Lumb, Alistair N. ;

Kowalski, Aaron ;

Rabasa-Lhoret, Remi ;

McCrimmon, Rory J. ;

Hume, Carin ;

Annan, Francesca ;

Fournier, Paul A. ;

Graham, Claudia ;

Bode, Bruce ;

Galassetti, Pietro ;

Jones, Timothy W. ;

Millan, Inigo San ;

Heise, Tim ;

Peters, Anne L. ;

Petz, Andreas ;

Laffel, Lori M. .

LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05) :377-390

[35]

Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO

[36]

2-O

[37] Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association [J].

Sherr, Jennifer L. ;

Heinemann, Lutz ;

Fleming, G. Alexander ;

Bergenstal, Richard M. ;

Bruttomesso, Daniela ;

Hanaire, Helene ;

Holl, Reinhard W. ;

Petrie, John R. ;

Peters, Anne L. ;

Evans, Mark .

DIABETOLOGIA, 2023, 66 (01) :3-22

[38] Target setting in intensive insulin management is associated with metabolic control: the Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005 [J].

Swift, P. G. F. ;

Skinner, T. C. ;

de Beaufort, C. E. ;

Cameron, F. J. ;

Aman, J. ;

Aanstoot, H-J ;

Castano, L. ;

Chiarelli, F. ;

Daneman, D. ;

Danne, T. ;

Dorchy, H. ;

Hoey, H. ;

Kaprio, E. A. ;

Kaufman, F. ;

Kocova, M. ;

Mortensen, H. B. ;

Njolstad, P. R. ;

Phillip, M. ;

Robertson, K. J. ;

Schoenle, E. J. ;

Urakami, T. ;

Vanelli, M. ;

Ackermann, R. W. ;

Skovlund, S. E. .

PEDIATRIC DIABETES, 2010, 11 (04) :271-278

[39] Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial [J].

Tauschmann, Martin ;

Thabit, Hood ;

Bally, Lia ;

Allen, Janet M. ;

Hartnell, Sara ;

Wilinska, Malgorzata E. ;

Ruan, Yue ;

Sibayan, Judy ;

Kolman, Craig ;

Cheng, Peiyao ;

Beck, Roy W. ;

Acerini, Carlo L. ;

Evans, Mark L. ;

Dunger, David B. ;

Elleri, Daniela ;

Campbell, Fiona ;

Bergenstal, Richard M. ;

Criego, Amy ;

Shah, Viral N. ;

Leelarathna, Lalantha ;

Hovorka, Roman .

LANCET, 2018, 392 (10155) :1321-1329

[40] Real-World Efficacy of the Hybrid Closed-Loop System [J].

Usoh, Chinenye O. ;

Johnson, Crystal Paige ;

Speiser, Jaime L. ;

Bundy, Richa ;

Dharod, Ajay ;

Aloi, Joseph A. .

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (03) :659-662

← 1 2 3 4 5 →